20 years of benefit for patients with Asthma in the UK¹

Offering the flexibility of three doses, Seretide (salmeterol/fluticasone propionate) allows patients to step up and down as needed; providing continuity of care and an individual approach to managing asthma control¹

Watch the video below to find out how Seretide could help support your patients who have asthma.

Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/GSKpro/UK/mp4/seretide-patient-success-story-video-asthma-uk-version-pm-gb-fps-vid-200001.mp4
Icon of a HCP with speech bubbles

More questions?

Arrange an appointment with one of our representatives. 

REQUEST A CONTACT
Resource image of peak flow meter, inhaler, leaflets for patients

Free patient resources

Order resources to support your patients including demo devices, leaflets and more.

ORDER NOW
Three stregngths of Seretide Evohaler MDI’s

Why Seretide?

Find out more about Seretide, including efficacy data, price, how to use and more.

FIND OUT MORE

References:

  1. Seretide Evohaler SPC

Seretide is a registered trademark of the GlaxoSmithKline group of companies

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

B.B. Sep 2020. PM-GB-FPS-WCNT-200006